S. Cox

发表

Experimental evaluation of foot-and-mouth disease vaccines for emergency use in ruminants and pigs: a review

P. Barnett, S. Cox, 2008, Veterinary research.

Experimental studies with foot-and-mouth disease virus, strain O, responsible for the 2001 epidemic in the United Kingdom.

R. Kitching, S. Alexandersen, Z. Zhang, 2002, Vaccine.

Further studies on the early protective responses of pigs following immunisation with high potency foot and mouth disease vaccine.

K. McCullough, P. Barnett, N. Aggarwal, 2002, Vaccine.

Emergency vaccination of sheep against foot-and-mouth disease: protection against disease and reduction in contact transmission.

J. Salt, P. Barnett, S. Cox, 1998, Vaccine.

Polyclonal and monoclonal antibodies to field and storage fungi

S. Cox, J. Banks, B. J. Northway, 1993 .

Porcine γδ T cells: Possible roles on the innate and adaptive immune responses following virus infection

P. Dash, H. Takamatsu, P. Barnett, 2006 .

Understanding foot-and-mouth disease virus transmission biology: identification of the indicators of infectiousness

M. Woolhouse, M. Chase-Topping, N. Juleff, 2013, Veterinary Research.

Modelling studies to estimate the prevalence of foot-and-mouth disease carriers after reactive vaccination

J. Wilesmith, M. Arnold, D. Paton, 2008, Proceedings of the Royal Society B: Biological Sciences.

A DNA vaccination regime including protein boost and electroporation protects cattle against foot-and-mouth disease.

H. Takamatsu, L. Robinson, P. Barnett, 2012, Antiviral research.

Evaluation of a monoclonal antibody-based approach for the selection of foot-and-mouth disease (FMD) vaccine strains.

N. Knowles, D. Paton, P. Barnett, 2008, Veterinary microbiology.

The role of small ruminants in the epidemiology and transmission of foot-and-mouth disease.

P. Barnett, S. Cox, S J Cox, 1999, Veterinary journal.

Longevity of antibody and cytokine responses following vaccination with high potency emergency FMD vaccines.

P. Barnett, N. Aggarwal, S. Cox, 2003, Vaccine.

Effect of emergency FMD vaccine antigen payload on protection, sub-clinical infection and persistence following direct contact challenge of cattle.

S. Reid, D. Paton, P. Barnett, 2006, Vaccine.

Evidence of partial protection against foot-and-mouth disease in cattle immunized with a recombinant adenovirus vector expressing the precursor polypeptide (P1) of foot-and-mouth disease virus capsid proteins.

F. Sobrino, A. Sanz-Parra, V. Ley, 1999, The Journal of general virology.

Foot-and-mouth disease marker vaccine: cattle protection with a partial VP1 G-H loop deleted virus antigen.

F. Maree, N. Knowles, P. Barnett, 2011, Vaccine.

The application of new techniques to the improved detection of persistently infected cattle after vaccination and contact exposure to foot-and-mouth disease.

S. Reid, D. Paton, P. Barnett, 2005, Vaccine.

Secretory IgA as an indicator of oro-pharyngeal foot-and-mouth disease virus replication and as a tool for post vaccination surveillance.

D. Paton, P. Barnett, S. Cox, 2006, Vaccine.

Interferon-gamma production in vitro from whole blood of foot-and-mouth disease virus (FMDV) vaccinated and infected cattle after incubation with inactivated FMDV.

S. Reid, B. Charleston, D. Paton, 2006, Vaccine.

Evidence that high potency foot-and-mouth disease vaccine inhibits local virus replication and prevents the "carrier" state in sheep.

S. Reid, P. Barnett, N. Aggarwal, 2004, Vaccine.

Differentiating infection from vaccination in foot-and-mouth-disease: evaluation of an ELISA based on recombinant 3ABC.

W. Vosloo, E. Brocchi, M. Forsyth, 2004, Veterinary microbiology.

Detection of antibody to the foot-and-mouth disease virus (FMDV) non-structural polyprotein 3ABC in sheep by ELISA.

D. Mackay, D. Paton, P. Barnett, 2005, Journal of virological methods.

Detection of IgG against the Foot-and-Mouth Disease Virus ( FMDV ) non-structural polyprotein 3 ABC in cattle and sheep

Z. Zhang, N. Aggarwal, S. Cox, 2003 .

Immune response characteristics following emergency vaccination of pigs against foot-and-mouth disease.

K. McCullough, A. Summerfield, P. Barnett, 2005, Vaccine.

Reducing animal experimentation in foot-and-mouth disease vaccine potency tests.

D. Haydon, R. Reeve, P. Barnett, 2011, Vaccine.

IL-6 production following vaccination in pigs--an additional immune response parameter for assessing FMD vaccine efficacy?

S. Gubbins, P. Barnett, S. Cox, 2011, Vaccine.

Protection against direct-contact challenge following emergency FMD vaccination of cattle and the effect on virus excretion from the oropharynx.

S. Reid, D. Paton, P. Barnett, 2005, Vaccine.

The Occurrence of dsRNA Species in Apparently Healthy and Virus-infected Ribes Cultivars, and Evidence That One Such Species Originates from a Member of the Virus Family Totiviridae

M. Mayo, A. Jones, S. Cox, 2000, European Journal of Plant Pathology.

Ribes host range and erratic distribution within plants of blackcurrant reversion associated virus provide further evidence for its role as the causal agent of reversion disease

A. Jones, A. Lemmetty, K. Lehto, 1997 .

Monoclonal antibodies to fungi of significance to the quality of foods and feeds

S. Cox, J. Banks, R. Rizvi, 1994 .

Porcine gammadelta T cells: possible roles on the innate and adaptive immune responses following virus infection.

P. Dash, H. Takamatsu, P. Barnett, 2006, Veterinary Immunology and Immunopathology.

WITHDRAWN: Foot-and-mouth disease: How much airborne virus do animals exhale?

S. Gubbins, C. Wright, D. Paton, 2008, Veterinary journal.

Further evaluation of higher potency vaccines for early protection of cattle against FMDV direct contact challenge.

S. Reid, D. Paton, P. Barnett, 2007, Vaccine.

Meta-analysis on the efficacy of foot-and-mouth disease emergency vaccination.

T. Halasa, A. Boklund, C. Enøe, 2011, Preventive veterinary medicine.